F16.21
BillableHallucinogen dependence, in remission
Hallucinogen dependence, in remission
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Other hallucinogen use disorder, moderate, in early remission
- Other hallucinogen use disorder, moderate, in sustained remission
- Other hallucinogen use disorder, severe, in early remission
- Other hallucinogen use disorder, severe, in sustained remission
- Phencyclidine use disorder, moderate, in early remission
- Phencyclidine use disorder, moderate, in sustained remission
- Phencyclidine use disorder, severe, in early remission
- Phencyclidine use disorder, severe, in sustained remission
Includes
Conditions included under this code
- disorders of psychological development
- ecstasy
- PCP
- phencyclidine
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
Related Codes(6)
F16.20Hallucinogen dependence, uncomplicated
F16.22Hallucinogen dependence with intoxication
F16.24Hallucinogen dependence w hallucinogen-induced mood disorder
F16.25Hallucinogen dependence w psychotic disorder
F16.28Hallucinogen dependence w oth hallucinogen-induced disorder
F16.29Hallucinogen dependence w unsp hallucinogen-induced disorder
Also Known As / Clinical Terms(23)
UMLS
- Hallucinogen Dependence, in RemissionC0154497
- Hallucinogen dependence in remissionC0154497
- Hallucinogen dependence in remission (disorder)C0154497
- Hallucinogen dependence, in remissionC0154497
- Other hallucinogen use disorder, moderate, in early remissionC4509072
- Other hallucinogen use disorder, moderate, in sustained remissionC4509073
- Other hallucinogen use disorder, severe, in early remissionC4509074
- Other hallucinogen use disorder, severe, in sustained remissionC4509075
- Phencyclidine use disorder, moderate, in early remissionC4481027
- Phencyclidine use disorder, moderate, in sustained remissionC4481028
- Phencyclidine use disorder, severe, in early remissionC4481029
- Phencyclidine use disorder, severe, in sustained remissionC4481030
Clinical Terms
- Other hallucinogen use disorder, severe, in early remission
- Hallucinogen dependence in remission
- Phencyclidine use disorder, severe, in early remission
- Hallucinogen dependence in remission (disorder)
- Other hallucinogen use disorder, moderate, in sustained remission
- Phencyclidine use disorder, moderate, in early remission
- Phencyclidine use disorder, moderate, in sustained remission
- Other hallucinogen use disorder, severe, in sustained remission
- Phencyclidine use disorder, severe, in sustained remission
- Other hallucinogen use disorder, moderate, in early remission
Frequently Asked Questions
What is the ICD-10 code for hallucinogen dependence, in remission?
The ICD-10-CM code for hallucinogen dependence, in remission is F16.21. The full clinical description is "Hallucinogen dependence, in remission". F16.21 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code F16.21 mean?
ICD-10-CM code F16.21 represents “Hallucinogen dependence, in remission”. It is classified under Chapter 5: Mental, Behavioral and Neurodevelopmental Disorders and is a billable/specific code that can be used on a claim.
Is F16.21 a billable code?
Yes, F16.21 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is F16.21 in?
F16.21 is in Chapter 5: Mental, Behavioral and Neurodevelopmental Disorders (codes F01-F99).
What codes cannot be used with F16.21?
F16.21 has Excludes1 notes indicating codes that cannot be used together with it, including: hallucinogen abuse (F16.1-); hallucinogen use, unspecified (F16.9-).
What SNOMED CT codes does F16.21 map to?
F16.21 maps to 1 SNOMED CT concept: 191851001. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for F16.21?
F16.21 is linked to 9 UMLS Concept Unique Identifiers: C0154497, C4509072, C4509073, C4509074, C4509075, and 4 more. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does F16.21 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like hallucinogen dependence, in remission affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of F16.21?
There is no direct ICD-11 mapping available for F16.21 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.